The present invention can provide a method for preparing a fermented nano-emulsifier composition comprising a product obtained by fermenting an oil with a skin flora, and a skin-friendly composition by minimizing the contents of synthetic raw materials according to such a method. Further, it is possible to improve an emulsification power by forming a nano-emulsion in a size of nm, to be adopted to various formulations by enhancing stability of the composition, and to be easily applied to various formulations requiring a function of hypoallergenic skin due to minimization of the skin irritation.

The present invention can provide a method for preparing a fermented nano-emulsifier composition comprising a product obtained by fermenting an oil with a skin flora, and a skin-friendly composition by minimizing the contents of synthetic raw materials according to such a method. Further, it is possible to improve an emulsification power by forming a nano-emulsion in a size of nm, to be adopted to various formulations by enhancing stability of the composition, and to be easily applied to various formulations requiring a function of hypoallergenic skin due to minimization of the skin irritation.

A composition comprising Lactobacillus paracasei and Saccharomyces boulardii is disclosed. The composition for use as a medicament, the composition for use in the treatment of a skin disease, a method of improving the appearance of the skin of a subject comprising orally administering the composition to the subject and a method of altering the microbiome of the skin of a subject comprising orally administering the composition to the subject are also disclosed.

A composition comprising Lactobacillus paracasei and Saccharomyces boulardii is disclosed. The composition for use as a medicament, the composition for use in the treatment of a skin disease, a method of improving the appearance of the skin of a subject comprising orally administering the composition to the subject and a method of altering the microbiome of the skin of a subject comprising orally administering the composition to the subject are also disclosed.

Compositions and methods for stimulating intrinsic hyaluronic acid production are provided herein. Compositions and methods for stimulating intrinsic hyaluronic acid production can improve skin moisture and elasticity.

Compositions and methods for stimulating intrinsic hyaluronic acid production are provided herein. Compositions and methods for stimulating intrinsic hyaluronic acid production can improve skin moisture and elasticity.

Disclosed is a method for treating skin. The method can include topically applying to skin in need thereof a composition comprising effective amounts of Arctium lappa root extract and Epilobium angustifolium extract to reduce expression of a pro-inflammatory cytokine of IL-8, IL-2, or TNF-α in the skin.

Disclosed is a method for treating skin. The method can include topically applying to skin in need thereof a composition comprising effective amounts of Arctium lappa root extract and Epilobium angustifolium extract to reduce expression of a pro-inflammatory cytokine of IL-8, IL-2, or TNF-α in the skin.

The present invention relates generally to methods and compositions useful for soothing skin inflammation in a subject. In some embodiments, methods and compositions disclosed herein comprise topical administration of a cosmetic formulation, wherein the cosmetic formulation comprises at least one transient receptor potential channel vanilloid subtype 1 (TRPV-1) antagonist. In some embodiments, the composition and/or method comprises plankton extract (e.g., saccharide isomerate), Phragmites communis (common reed) extract, Poria cocos (China root) extract, and/or Cucurbita pepo (pumpkin) seed extract.

The present invention relates generally to methods and compositions useful for soothing skin inflammation in a subject. In some embodiments, methods and compositions disclosed herein comprise topical administration of a cosmetic formulation, wherein the cosmetic formulation comprises at least one transient receptor potential channel vanilloid subtype 1 (TRPV-1) antagonist. In some embodiments, the composition and/or method comprises plankton extract (e.g., saccharide isomerate), Phragmites communis (common reed) extract, Poria cocos (China root) extract, and/or Cucurbita pepo (pumpkin) seed extract.